Efficacy of and tolerance to exemestane (E) versus tamoxifen (T) in first line hormone therapy (HT) of postmenopausal metastatic breast cancer (MBC) patients (pts) : a European Organisation for the Research and Treatment of Cancer (EORTC Breast Group) phase II trial with Pharmacia and Upjohn

• DIRIX L

収録刊行物

• Proc Am Soc Clin Oncol

  Proc Am Soc Clin Oncol 20 29a-, 2001

詳細情報

• CRID: 1572261549871493632
• NII論文ID: 10011164238
• データソース種別:
  • CiNii Articles